Safety and BNT162b2 mRNA COVID-19 vaccination
Keywords:
safety, covid, vaccineAbstract
n/a
References
Vigezzi GP, Lume A, Minerva M, Nizzero P, Biancardi A, Gianfredi V, Odone A, Signorelli C, Moro M. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed [Internet]. 2021 Oct. 1 [cited 2021 Oct. 4];92(S6):e2021450.
Mishra S, Mungmunpuntipantip I. Editorial: a good case report that might not be accepted for publication in a journal. Case Study Case Rep. 2021; 11(3): 32 - 33.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Beuy Joob
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
